| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |